Drug-Drug Interactions: Understanding Proposed FDA Regulatory Updates and Applying In Vitro and Physiologically Based Techniques
December 17, 2018 - Toronto ON CAXtalks
fbonilla@xtalks.com
Phone:1 416.977.6555
In this webinar feature speakers will: Review the proposed changes to the FDA regulatory guidance to ensure that the appropriate data are being captured in your drug development program Explore what else can be done with data to better understand enzymes, transporters and drug disposition Present case studies demonstrating the use of PBPK models to simulate potential exposure changes of both the victim and perpetrator compounds and discuss how these results can be used in regulatory conversations and how they can help you design additional experiments to optimize your program
This website uses cookies to ensure you get the best experience on our website. Learn more